Clinical Trial Update: Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study [NA]

View source ↗

Summary

This document reports a Brazilian clinical trial update on corneal collagen crosslinking with riboflavin (vitamin B2) and UV-A light for treating keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Riboflavin (riboflavin)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Keratoconus | NA | Status: UNKNOWN